Olazax Disperzi
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Olazax Disperzi, covering 2020-06-16 to 2020-06-16. Get the full timeline:
Most recent: EMA Authorised: Olazax Disperzi (olanzapine) — Glenmark Pharmaceuticals s.r.o.